Transcode Therapeutics, Inc. (RNAZ)

CIK 1829635 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Transcode Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 28, 20268-K0001104659-26-119658
Oct 1, 20268-K0001104659-26-112826
Sep 28, 20268-K0001104659-26-111170
Sep 21, 202630001104659-26-109371
Sep 11, 20268-K0001104659-26-107115
Sep 11, 202640001104659-26-107120
Aug 14, 202610-Q0001829635-26-000003
Aug 5, 202630001104659-26-091074
Aug 5, 202640001104659-26-091078
Aug 3, 20268-K0001104659-26-089805
Aug 3, 2026SCHEDULE 13D/A0001104659-26-089819
Jul 28, 2026SCHEDULE 13G0001493152-26-035074
Jul 28, 2026SCHEDULE 13G0001493152-26-035075
Jul 28, 2026SCHEDULE 13G0001493152-26-035076
Jul 27, 2026SCHEDULE 13D/A0001104659-26-087098
Jul 23, 2026SCHEDULE 13D/A0001104659-26-086266
Jul 20, 2026424B30001104659-26-085105
Jul 20, 20268-K0001104659-26-085073
Jul 20, 2026424B30001104659-26-085107
Jul 17, 20268-K0001104659-26-084617
Jul 17, 2026DEFA14A0001104659-26-084628
Jul 17, 2026SCHEDULE 13D/A0001104659-26-084636
Jul 2, 20268-K0001104659-26-080311
Jun 18, 20268-K0001104659-26-075440
Jun 3, 20268-K0001104659-26-069810